|
µî·ÏÀÏ:
2004-03-16 21:50:58 , Á¶È¸:
2,240 |
1. ÀÓ»óÀÇ ¹è°æ:
¾ÆÅäÇÇÇǺο°Àº ÀÏ»óÀûÀÎ »ýÈ°, ·¹Á®, Çо÷ ¹× Á÷Àå»ýÈ°, ´ëÀΰü°è µî ȯÀÚÀÇ »îÀÇ Áú¿¡ ¹ÌÄ¡´Â ¿µÇâÀÌ ¸Å¿ì Å©¸ç, ¾ÆÅäÇÇÇǺο°ÀÇ Ä¡·á¹ý ¿ª½Ã ¿µÇâÀ» ¹ÌÄ¡°Ô µÈ´Ù.
2. ÀÓ»óÀÇ ¹æ¹ý
¼ºÀÎ(adults) 579¸í, ¼Ò¾Æ(children) 178¸í, À¯¾Æ(toddler) 145¸íÀ» ´ë»óÀ¸·Î 12ÁÖ µ¿¾È ÇÁ·ÎÅäÇÈ°ú ±âÁ¦·Î Ä¡·áÇÏ¸é¼ »îÀÇ ÁúÀ» ÃøÁ¤ÇÏ¿´À½.
ÃøÁ¤Àº DLQI(Dermatology Life Quality Index), CDLQI (Children¡¯s DLQI), Toddler QOL Survey·Î ÇÔ.
3. ÀÓ»óÀÇ °á°ú
ÇÁ·ÎÅäÇÈ Ä¡·á·Î ÀÎÇÑ »îÀÇ Áú Çâ»óµµ °á°ú:
¼ºÀΠȯÀÚÀÇ 80%, ¼Ò¾Æ ȯÀÚÀÇ 60%, À¯¾ÆȯÀÚÀÇ 85%°¡ ¾ÆÅäÇÇÇǺο°À¸·Î ÀÎÇØ »îÀÌ Å« ¿µÇâÀ» ¹Þ´Â´Ù°í ´ë´äÇÏ¿´À½.
ÇÁ·ÎÅäÇÈ Ä¡·á ÈÄ ¼ºÀÎ, ¼Ò¾Æ, À¯¾ÆÀÇ ¸ðµç ±×·ì¿¡¼ »îÀÇ ÁúÀÌ Çâ»óµÈ °á°ú°¡ ³ªÅ¸³µÀ½.
ƯÈ÷ ¼ºÀÎÀÇ °æ¿ì ¾ÆÅäÇÇ Áõ»ó°ú ´À³¦, Çо÷°ú Á÷Àå»ýÈ°ÀÇ ºÎºÐ¿¡¼ °¡Àå Å« Çâ»óÀÌ ÀÖ¾ú°í, ¼Ò¾Æ¿Í À¯¾ÆÀÇ °æ¿ì ¾ÆÅäÇÇ Áõ»ó°ú ´À³¦, ¼ö¸é¿¡¼ °¡Àå Å« Çâ»óÀÌ ÀÖ¾úÀ½.
ÇÁ·ÎÅäÇÈ »ç¿ë¼±È£µµ °á°ú:
¼ºÀο¡¼ 74%, ¼Ò¾Æ¿¡¼ 83%, À¯¾Æ¿¡¼ 88%°¡ ÀÓ»ó ÈÄ ÇÁ·ÎÅäÇÈÀ¸·Î °è¼Ó Ä¡·á ¹Þ±â¸¦ Èñ¸ÁÇÏ¿´À½.
4. ÀÓ»óÀÇ °á·Ð:
ÇÁ·ÎÅäÇÈ ¿¬°í´Â ¾ÆÅäÇÇÇǺο° ȯÀÚÀÇ ½ÅüÀû, Á¤½ÅÀûÀÎ »îÀÇ ÁúÀ» ³ôÀ̴µ¥ ±â¿©ÇÏ¿´°í, ´ëºÎºÐÀÇ È¯ÀÚ°¡ ÀÓ»ó ÈÄ ÇÁ·ÎÅäÇÈÀ¸·Î °è¼Ó Ä¡·á ¹Þ±â¸¦ Èñ¸ÁÇÏ¿´´Ù.
¹ßÃé : Lynn Drake, MD, Debra Breneman, MD, et al. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. Journal of the American Academy of Dermatology2001: 44:s47-57
|
|